Other studies have investigated the heterogeneity of CML-SC (stem cells) and bone marrow CD34+ cells in AML patients, and NK cells from the bone marrow of AML patients and healthy individuals (80–82). The gene discussed is CD34; the disease is acute myeloid leukemia.